1. Photodynamic therapy of cancer: an update;Agostinis;CA Cancer J. Clin.,2011
2. Ajai Pal, S.K., Yue-Fen Wang, Narayan Kamath, Asis K. Sarkar, Ateeq Ahmad, Saifuddin Sheikh, Shahid Ali, Danielle Carbonaro, Allen Zhang, Imran, Ahmad, 2005. Preclinical asfety pharmacokinetics and antitumor efficacy profile of liposome entrapped SN-38 formulation. Anticancer Res., 25, 331-342.
3. Poloxamer-linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high-risk neuroblastoma with primary and acquired chemoresistance;Alferiev;FASEB J.,2022
4. Nanocarrier-based delivery of SN22 as a tocopheryl oxamate prodrug achieves rapid tumor regression and extends survival in high-risk neuroblastoma models;Alferiev;Int. J. Mol. Sci.,2022
5. Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project;Applebaum;Eur. J. Cancer,2017